Effects of tDCS Combined With CBI on Postsurgical Pain
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Dec 12, 2019
Trial Information
Current as of July 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a new treatment can help reduce pain after total knee or hip replacement surgery. The treatment involves a technique called transcranial direct current stimulation (tDCS), which uses a gentle electrical current to stimulate parts of the brain that may help lessen pain. This method is used alongside a Cognitive-Behavioral intervention (CBI), which helps patients manage their thoughts and feelings about pain. The goal is to see if this combination can lower pain levels and reduce the need for strong pain medications after surgery.
To participate in the study, you need to be a patient scheduled for knee or hip replacement surgery at the Ralph H. Johnson VAMC in Charleston, SC, and you should be able to read, write, and follow instructions in English. The study is open to a wide age range of veterans, and you cannot have certain medical conditions, like implanted devices above the waist or a history of seizures. Participants will be randomly assigned to one of the treatment groups and will be monitored for 48 hours post-surgery to assess their pain and functioning. This trial aims to provide valuable insights into how these new techniques can improve recovery after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will be 120 patients (132 recruited to account for 10% drop-out rate) undergoing TKA or THA surgery at the Ralph H. Johnson VAMC in Charleston SC.
- • Mentally capable of reading, writing, giving consent, and following instructions
- • Cleared for, and scheduled for unilateral TKA or THA surgery
- • Able to hear CB intervention and understand educational materials through headphones in English
- Exclusion Criteria:
- • implanted medical devices above the waist
- • pregnant
- • history of seizures
- • allergic to latex rubber
- • psychiatric conditions except for depression and/or anxiety disorders (commonly seen in this population).
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Charleston, South Carolina, United States
Patients applied
Trial Officials
Jeffrey J Borckardt, PhD
Principal Investigator
Ralph H. Johnson VA Medical Center, Charleston, SC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials